Eicher Motors Limited Announces Appointment of B Govindarajan as CEO of Royal Enfield

#EicherMotors #BGovindarajan #RoyalEnfield

Source: Eicher Motors

Mr. Govindarajan has spent more than 23 years across Royal Enfield and Eicher Motors. He has been the Executive Director of Royal Enfield since August 2021, and was Chief Operating Officer of the company since 2013.

May 2022 : Subsequent to the Board of Directors meeting held on Friday, May 13, 2022, Eicher Motors Ltd. has announced the appointment of B Govindarajan as Chief Executive Officer of Royal Enfield. With this appointment, Govindarajan will now be CEO - Royal Enfield, and Wholetime Director on the Board of Eicher Motors Ltd.

B Govindarajan’s appointment as CEO - Royal Enfield is in line with the company’s long term ambitions, strategic growth plans, and a strong product launch line-up over the coming years. With his robust business & technical knowledge, sharp understanding of the industry, strong leadership skills and tenured experience in the industry and at Royal Enfield, Govindarajan is all set to take Royal Enfield to new heights.

He has led several turnkey projects and has been instrumental in growing and expanding the company’s manufacturing facilities, in addition to bringing a paradigm shift in the product quality and new product development process. He has actively led the production ramp up at Royal Enfield and spearheaded the establishment of its two new world-class manufacturing facilities at Oragadam and Vallam Vadagal near Chennai and the state-of-the-art Technology Centres in the UK and in Chennai, India. During his tenure, Mr. Govindarajan has ably straddled business and technical roles with ease and has led commercial operations between 2013 and 2015. He has led the successful development and launch of several award winning motorcycles at Royal Enfield including the Himalayan, the 650 Twin platform and motorcycles, and more recently, the J-series platform with the all-new Meteor and Classic 350. He has been instrumental in furthering the company’s global ambitions by establishing subsidiaries, and CKD operations across critical markets.